NP / PA
U. S. Anesthesia Partners of Texas, P.A.,
U. S. Anesthesia Partners of Texas, P.A., was paid $16.74M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 01967, Neuraxial labor analgesia/anesthesia for planned vaginal delivery — 76% of everything it billed.
33Billing provider infoU. S. ANESTHESIA PARTNERS OF TEXAS, P.A.,
HOUSTON, TX 77042
HOUSTON, TX 77042
33aNPI1548208564assigned 06/03/2006
33bProvider typeCertified Registered Nurse Anesthetist
28Total paid$16.74M
24GClaims84,017
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Certified Registered Nurse Anesthetist providers in Texas
Rank by total paid#1 of 67
Median peer was paid$31K
This provider vs. median535×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,442 | $23K | |
| 2019 | 15 | $300.05 | |
| 2020 | 3,094 | $651K | |
| 2021 | 16,047 | $3.62M | |
| 2022 | 20,728 | $4.49M | |
| 2023 | 22,354 | $4.59M | |
| 2024incomplete | 18,337 | $3.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 76% | 52,348 | 50,012 | $12.67M |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 16% | 13,652 | 13,152 | $2.67M |
| 01961 | 4.7% | 3,354 | 3,235 | $791K | |
| 01922 | 1.1% | 699 | 682 | $189K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1.1% | 7,901 | 6,893 | $185K |
| 00126 | <1% | 697 | 669 | $75K | |
| 00140 | <1% | 316 | 300 | $37K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 2,204 | 2,144 | $20K |
| 99140 | <1% | 197 | 191 | $12K | |
| 00840 | <1% | 59 | 53 | $11K | |
| 64999 | <1% | 124 | 119 | $11K | |
| 00920 | <1% | 58 | 58 | $11K |
24 more codes
| 00731 | <1% | 101 | $9K | |
| 00142 | <1% | 156 | $7K | |
| 01968 | <1% | 80 | $7K | |
| 01996 | <1% | 448 | $6K | |
| 99100 | <1% | 84 | $6K | |
| 00813 | <1% | 39 | $5K | |
| 01936 | <1% | 25 | $4K | |
| 64488 | <1% | 96 | $2K | |
| 01938 | <1% | 15 | $2K | |
| 01992 | <1% | 49 | $1K | |
| 76942 | <1% | 70 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 181 | $1K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 27 | $564.81 |
| 64425 | <1% | 13 | $514.15 | |
| 36620 | <1% | 13 | $266.65 | |
| 76937 | <1% | 23 | $172.89 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 45 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 58 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 59 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 63 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 610 | $0.00 |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 0% | 27 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 111 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRALSTON, ALVIN (PRESIDENT)